BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32771416)

  • 1. A machine learning framework to trace tumor tissue-of-origin of 13 types of cancer based on DNA somatic mutation.
    He B; Dai C; Lang J; Bing P; Tian G; Wang B; Yang J
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165916. PubMed ID: 32771416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence.
    Zhao Y; Pan Z; Namburi S; Pattison A; Posner A; Balachander S; Paisie CA; Reddi HV; Rueter J; Gill AJ; Fox S; Raghav KPS; Flynn WF; Tothill RW; Li S; Karuturi RKM; George J
    EBioMedicine; 2020 Nov; 61():103030. PubMed ID: 33039710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating DNA Methylation, Gene Expression, Somatic Mutation, and Their Combinations in Inferring Tumor Tissue-of-Origin.
    Liu H; Qiu C; Wang B; Bing P; Tian G; Zhang X; Ma J; He B; Yang J
    Front Cell Dev Biol; 2021; 9():619330. PubMed ID: 34012960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Cancer Tissue-of-Origin by a Machine Learning Method Using DNA Somatic Mutation Data.
    Liu X; Li L; Peng L; Wang B; Lang J; Lu Q; Zhang X; Sun Y; Tian G; Zhang H; Zhou L
    Front Genet; 2020; 11():674. PubMed ID: 32760423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features.
    Nguyen L; Van Hoeck A; Cuppen E
    Nat Commun; 2022 Jul; 13(1):4013. PubMed ID: 35817764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOOme: A Novel Computational Framework to Infer Cancer Tissue-of-Origin by Integrating Both Gene Mutation and Expression.
    He B; Lang J; Wang B; Liu X; Lu Q; He J; Gao W; Bing P; Tian G; Yang J
    Front Bioeng Biotechnol; 2020; 8():394. PubMed ID: 32509741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOD-CUP: a gene expression rank-based majority vote algorithm for tissue origin diagnosis of cancers of unknown primary.
    Shen Y; Chu Q; Yin X; He Y; Bai P; Wang Y; Fang W; Timko MP; Fan L; Jiang W
    Brief Bioinform; 2021 Mar; 22(2):2106-2118. PubMed ID: 32266390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cross-cohort computational framework to trace tumor tissue-of-origin based on RNA sequencing.
    He B; Sun H; Bao M; Li H; He J; Tian G; Wang B
    Sci Rep; 2023 Sep; 13(1):15356. PubMed ID: 37717102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue of origin prediction for cancer of unknown primary using a targeted methylation sequencing panel.
    Sun M; Xu B; Chen C; Zhu Y; Li X; Chen K
    Clin Epigenetics; 2024 Feb; 16(1):25. PubMed ID: 38336771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary.
    Posner A; Prall OW; Sivakumaran T; Etemadamoghadam D; Thio N; Pattison A; Balachander S; Fisher K; Webb S; Wood C; DeFazio A; Wilcken N; Gao B; Karapetis CS; Singh M; Collins IM; Richardson G; Steer C; Warren M; Karanth N; Wright G; Williams S; George J; Hicks RJ; Boussioutas A; Gill AJ; Solomon BJ; Xu H; Fellowes A; Fox SB; Schofield P; Bowtell D; Mileshkin L; Tothill RW
    J Pathol; 2023 Jan; 259(1):81-92. PubMed ID: 36287571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.
    Lorkowski SW; Dermawan JK; Rubin BP
    Virchows Arch; 2024 Feb; 484(2):369-375. PubMed ID: 37999736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of unknown primary.
    Tothill RW; Li J; Mileshkin L; Doig K; Siganakis T; Cowin P; Fellowes A; Semple T; Fox S; Byron K; Kowalczyk A; Thomas D; Schofield P; Bowtell DD
    J Pathol; 2013 Dec; 231(4):413-23. PubMed ID: 24037760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular approach integrating genomic and DNA methylation profiling for tissue of origin identification in lung-specific cancer of unknown primary.
    Chen K; Zhang F; Yu X; Huang Z; Gong L; Xu Y; Li H; Yu S; Fan Y
    J Transl Med; 2022 Apr; 20(1):158. PubMed ID: 35382836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying cancer tissue-of-origin by a novel machine learning method based on expression quantitative trait loci.
    Miao Y; Zhang X; Chen S; Zhou W; Xu D; Shi X; Li J; Tu J; Yuan X; Lv K; Tian G
    Front Oncol; 2022; 12():946552. PubMed ID: 36016607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNooPer: a machine learning-based method for somatic variant identification from low-pass next-generation sequencing.
    Spinella JF; Mehanna P; Vidal R; Saillour V; Cassart P; Richer C; Ouimet M; Healy J; Sinnett D
    BMC Genomics; 2016 Nov; 17(1):912. PubMed ID: 27842494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA-Seq accurately identifies cancer biomarker signatures to distinguish tissue of origin.
    Wei IH; Shi Y; Jiang H; Kumar-Sinha C; Chinnaiyan AM
    Neoplasia; 2014 Nov; 16(11):918-27. PubMed ID: 25425966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cfDNA methylation-based tissue-of-origin classifier for cancers of unknown primary.
    Conway AM; Pearce SP; Clipson A; Hill SM; Chemi F; Slane-Tan D; Ferdous S; Hossain ASMM; Kamieniecka K; White DJ; Mitchell C; Kerr A; Krebs MG; Brady G; Dive C; Cook N; Rothwell DG
    Nat Commun; 2024 Apr; 15(1):3292. PubMed ID: 38632274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary.
    Moon I; LoPiccolo J; Baca SC; Sholl LM; Kehl KL; Hassett MJ; Liu D; Schrag D; Gusev A
    Nat Med; 2023 Aug; 29(8):2057-2067. PubMed ID: 37550415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A second-generation microRNA-based assay for diagnosing tumor tissue origin.
    Meiri E; Mueller WC; Rosenwald S; Zepeniuk M; Klinke E; Edmonston TB; Werner M; Lass U; Barshack I; Feinmesser M; Huszar M; Fogt F; Ashkenazi K; Sanden M; Goren E; Dromi N; Zion O; Burnstein I; Chajut A; Spector Y; Aharonov R
    Oncologist; 2012; 17(6):801-12. PubMed ID: 22618571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of Cancer Primary Sites Using Machine Learning and Somatic Mutations.
    Chen Y; Sun J; Huang LC; Xu H; Zhao Z
    Biomed Res Int; 2015; 2015():491502. PubMed ID: 26539502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.